Hwail Pharmaceutical Co.Ltd (061250) — Long-term Investment Intensity
Hwail Pharmaceutical Co.Ltd (061250) has a Long-term Investment Intensity of 6.1% as of March 2017. Long-term investments of ₩7.77 Billion represent 6.1% of total assets of ₩127.96 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check 061250 cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
LT Investment Intensity
Long-term Investments
Total Assets
Country
Hwail Pharmaceutical Co.Ltd Long-term Investment Intensity (2013–2016)
This chart shows how Hwail Pharmaceutical Co.Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2013 to 2016. As of March 2017, the intensity stands at 6.1%, reflecting long-term investments of ₩7.77 Billion against total assets of ₩127.96 Billion KRW. Explore debt repayment capacity of Hwail Pharmaceutical Co.Ltd to assess how comfortably operating cash covers total debt obligations.
Annual Long-term Investment Intensity for Hwail Pharmaceutical Co.Ltd (2013–2016)
The table below presents the year-by-year Long-term Investment Intensity for Hwail Pharmaceutical Co.Ltd from 2013 to 2016, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. For market capitalisation and broader financial context, see Hwail Pharmaceutical Co.Ltd market cap and net worth.
| Year | LT Investment Intensity | LT Investments (KRW) | Total Assets | Change (pp) |
|---|---|---|---|---|
| 2016 | 6.8% | ₩8.78 Billion | ₩128.62 Billion | ▼ -2.4 pp |
| 2015 | 9.2% | ₩12.96 Billion | ₩140.27 Billion | ▲ +8.3 pp |
| 2014 | 1.0% | ₩1.18 Billion | ₩122.92 Billion | ▼ -1.7 pp |
| 2013 | 2.6% | ₩3.23 Billion | ₩123.02 Billion | — |